Tranexamic acid for preventing postpartum blood loss at cesarean delivery: is evidence sufficient?

Acta Obstet Gynecol Scand. 2016 Jul;95(7):836. doi: 10.1111/aogs.12864. Epub 2016 Mar 7.

Authors

Loïc Sentilhes¹, Stéphanie Brun¹, Hugo Madar¹, Catherine Deneux-Tharaux²

Affiliations

¹ Department of Obstetrics and Gynecology, Bordeaux University Hospital, Bordeaux, France.
² Obstetrical, Perinatal and Pediatric Epidemiology Research Team, Center for Epidemiology and Biostatistics (U1153), INSERM, Paris-Descartes University, Paris, France.

PMID: 26866717
DOI: 10.1111/aogs.12864

No abstract available

Publication types

Letter

MeSH terms

Antifibrinolytic Agents / therapeutic use*
Cesarean Section*
Female
Humans
Postpartum Hemorrhage / prevention & control*
Pregnancy
Randomized Controlled Trials as Topic
Tranexamic Acid / therapeutic use*

Substances

Antifibrinolytic Agents
Tranexamic Acid